%0 Journal Article
%A Hernández Sánchez, María
%T CRISPR/Cas9 in Chronic Lymphocytic Leukemia
%D 2022
%@ 2673-8392
%U https://hdl.handle.net/20.500.14352/72090
%X Genome-editing systems such as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 technology have uncovered new opportunities to model diseases such as chronic lymphocytic leukemia. CRISPR/Cas9 is an important means of advancing functional studies of Chronic Lymphocytic Leukemia (CLL) through the incorporation, elimination and modification of somatic mutations in CLL models.
%~